SYRE logo

Spyre Therapeutics (SYRE) Total Liabilities

Annual Total Liabilities

$157.84 M
+$137.00 M+657.44%

December 31, 2023


Summary


Performance

SYRE Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSYREbalance sheetmetrics:

Quarterly Total Liabilities

$93.70 M
+$32.02 M+51.91%

September 30, 2024


Summary


Performance

SYRE Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSYREbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

SYRE Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+657.4%0.0%
3 y3 years+624.5%+290.2%
5 y5 years+1430.8%+290.2%

SYRE Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+657.4%-79.3%+398.4%
5 y5-yearat high+657.4%-79.3%+398.4%
alltimeall timeat high>+9999.0%-79.3%+8756.2%

Spyre Therapeutics Total Liabilities History

DateAnnualQuarterly
Sep 2024
-
$93.70 M(+51.9%)
Jun 2024
-
$61.68 M(-81.6%)
Mar 2024
-
$335.33 M(+112.4%)
Dec 2023
$157.84 M(+657.4%)
$157.84 M(-65.1%)
Sep 2023
-
$452.67 M(+0.4%)
Jun 2023
-
$450.90 M(+2298.3%)
Mar 2023
-
$18.80 M(-9.8%)
Dec 2022
$20.84 M(-19.8%)
-
Dec 2022
-
$20.84 M(-13.2%)
Sep 2022
-
$24.01 M(+6.5%)
Jun 2022
-
$22.55 M(+4.8%)
Mar 2022
-
$21.51 M(-17.2%)
Dec 2021
$25.98 M(+19.3%)
$25.98 M(-3.7%)
Sep 2021
-
$26.98 M(-3.5%)
Jun 2021
-
$27.96 M(-29.9%)
Mar 2021
-
$39.86 M(+83.0%)
Dec 2020
$21.79 M(-5.7%)
$21.79 M(+12.5%)
Sep 2020
-
$19.36 M(-6.3%)
Jun 2020
-
$20.65 M(-6.0%)
Mar 2020
-
$21.98 M(-4.9%)
Dec 2019
$23.10 M
$23.10 M(+13.8%)
DateAnnualQuarterly
Sep 2019
-
$20.30 M(+13.5%)
Jun 2019
-
$17.88 M(+46.2%)
Mar 2019
-
$12.23 M(+18.6%)
Dec 2018
$10.31 M(+79.6%)
$10.31 M(+35.7%)
Sep 2018
-
$7.60 M(+21.2%)
Jun 2018
-
$6.27 M(+6.8%)
Mar 2018
-
$5.87 M(+2.2%)
Dec 2017
$5.74 M(+40.1%)
$5.74 M(+14.9%)
Sep 2017
-
$4.99 M(+10.0%)
Jun 2017
-
$4.54 M(+11.2%)
Mar 2017
-
$4.08 M(-0.3%)
Dec 2016
$4.10 M(+60.7%)
$4.10 M(+6.1%)
Sep 2016
-
$3.86 M(+14.4%)
Jun 2016
-
$3.38 M(-12.1%)
Mar 2016
-
$3.84 M(+50.7%)
Dec 2015
$2.55 M(+141.0%)
$2.55 M(+4.0%)
Sep 2015
-
$2.45 M(-10.5%)
Jun 2015
-
$2.74 M(+122.6%)
Mar 2015
-
$1.23 M(+16.3%)
Dec 2014
$1.06 M(-25.1%)
$1.06 M
Dec 2013
$1.41 M
-

FAQ

  • What is Spyre Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Spyre Therapeutics?
  • What is Spyre Therapeutics annual total liabilities year-on-year change?
  • What is Spyre Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Spyre Therapeutics?
  • What is Spyre Therapeutics quarterly total liabilities year-on-year change?

What is Spyre Therapeutics annual total liabilities?

The current annual total liabilities of SYRE is $157.84 M

What is the all time high annual total liabilities for Spyre Therapeutics?

Spyre Therapeutics all-time high annual total liabilities is $157.84 M

What is Spyre Therapeutics annual total liabilities year-on-year change?

Over the past year, SYRE annual total liabilities has changed by +$137.00 M (+657.44%)

What is Spyre Therapeutics quarterly total liabilities?

The current quarterly total liabilities of SYRE is $93.70 M

What is the all time high quarterly total liabilities for Spyre Therapeutics?

Spyre Therapeutics all-time high quarterly total liabilities is $452.67 M

What is Spyre Therapeutics quarterly total liabilities year-on-year change?

Over the past year, SYRE quarterly total liabilities has changed by $0.00 (0.00%)